6 Dimensions Capital, L.P. - Net Worth and Insider Trading

6 Dimensions Capital, L.P. Net Worth

The estimated net worth of 6 Dimensions Capital, L.P. is at least $529 Million dollars as of 2024-12-25. 6 Dimensions Capital, L.P. is the 2101 Beneficial owner of Ocumension Therapeutics and owns about 119,890,000 shares of Ocumension Therapeutics (HKSE:01477) stock worth over $529 Million. Details can be seen in 6 Dimensions Capital, L.P.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that 6 Dimensions Capital, L.P. has not made any transactions after 2024-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of 6 Dimensions Capital, L.P.

To

6 Dimensions Capital, L.P. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, 6 Dimensions Capital, L.P. owns 1 companies in total, including Ocumension Therapeutics (HKSE:01477) .

Click here to see the complete history of 6 Dimensions Capital, L.P.’s form 4 insider trades.

Insider Ownership Summary of 6 Dimensions Capital, L.P.

Ticker Comapny Transaction Date Type of Owner
HKSE:01477 Ocumension Therapeutics 2021-12-21 2101 Beneficial owner

6 Dimensions Capital, L.P. Latest Holdings Summary

6 Dimensions Capital, L.P. currently owns a total of 1 stock. 6 Dimensions Capital, L.P. owns 119,890,000 shares of Ocumension Therapeutics (HKSE:01477) as of October 16, 2024, with a value of $529 Million.

Latest Holdings of 6 Dimensions Capital, L.P.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01477 Ocumension Therapeutics 2024-10-16 119,890,000 4.41 528,714,900

Holding Weightings of 6 Dimensions Capital, L.P.


6 Dimensions Capital, L.P. Form 4 Trading Tracker

According to the SEC Form 4 filings, 6 Dimensions Capital, L.P. has made a total of 2 transactions in Ocumension Therapeutics (HKSE:01477) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Ocumension Therapeutics is the sale of 0 shares on October 16, 2024, which brought 6 Dimensions Capital, L.P. around $0.

Insider Trading History of 6 Dimensions Capital, L.P.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

6 Dimensions Capital, L.P. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

6 Dimensions Capital, L.P. Ownership Network

Ownership Network List of 6 Dimensions Capital, L.P.

No Data

Ownership Network Relation of 6 Dimensions Capital, L.P.

Insider Network Chart

6 Dimensions Capital, L.P. Owned Company Details

What does Ocumension Therapeutics do?

Who are the key executives at Ocumension Therapeutics?

6 Dimensions Capital, L.P. is the 2101 Beneficial owner of Ocumension Therapeutics. Other key executives at Ocumension Therapeutics include 2201 Interest of corporation controlled by you ZHANG Qiping , 2201 Interest of corporation controlled by you su zhou fu yan chuang ye tou zi guan li he huo qi ye you xian he huo , and 2201 Interest of corporation controlled by you 6 Dimensions Capital GP, LLC .

Ocumension Therapeutics (HKSE:01477) Insider Trades Summary

Over the past 18 months, 6 Dimensions Capital, L.P. made no insider transaction in Ocumension Therapeutics (HKSE:01477). Other recent insider transactions involving Ocumension Therapeutics (HKSE:01477) include a net sale of 0 shares made by Liu Ye , a net sale of 3,800,000 shares made by Temasek Holdings (private) Limited , and a net purchase of 150,000 shares made by Boyu Capital Group Holdings Ltd .

In summary, during the past 3 months, insiders sold 0 shares of Ocumension Therapeutics (HKSE:01477) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,227,000 shares of Ocumension Therapeutics (HKSE:01477) were sold and 150,000 shares were bought by its insiders, resulting in a net sale of 4,077,000 shares.

Ocumension Therapeutics (HKSE:01477)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ocumension Therapeutics Insider Transactions

No Available Data

6 Dimensions Capital, L.P. Mailing Address

Above is the net worth, insider trading, and ownership report for 6 Dimensions Capital, L.P.. Currently GuruFocus does not have mailing address information for 6 Dimensions Capital, L.P..

Discussions on 6 Dimensions Capital, L.P.

No discussions yet.